Skip to main content
. 2023 Dec 17;11(12):3336. doi: 10.3390/biomedicines11123336

Table 4.

Comparison of demographic, cognitive, and neuropsychiatric data in pre-manifest HD participants according to calculated years to onset: +: higher scores = better performance; #: higher scores = more impairment.

Years to
Calculated Onset
<5 y
n = 138
5–<10 y
n = 1242
10–<15 y
n = 1215
15–<20 y
n = 920
>20 y
n = 1634
F p Part. Eta2
Years to onset
M (SD)
4.43 (0.47) 7.71 (1.40) 12.44 (1.43) 17.33 (1.43) 29.00 (8.60) 3938.84 <0.001 0.754
TFC; M (SD) + 12.51 (0.97) 12.54 (1.01) 12.70 (0.97) 12.78 (0.90) 12.85 (0.74) 22.01 <0.001 0.017
Age (y); M (SD) 44.61 (9.35) 46.78 (12.17) 41.54 (11.98) 32.22 (10.30) 33.76 (9.73) 267.16 <0.001 0.172
CAG; M(SD) 46.38 (2.94) 43.55 (2.95) 42.96 (2.73) 42.24 (2.11) 40.76 (1.94) 256.36 <0.001 0.217
Sex (f/m) (%f) 70/68 (50.7) 177/509 (59.0) 705/510 (58.0) 591/329 (64.2) 987/647 (60.4) 14.40 <0.010 0.006
ISCED 3.93 (1.16) 3.83 (1.16) 3.91 (1.13) 4.01 (1.09) 4.06 (1.08) 8.68 <0.001 0.007
CAP-Score; M (SD) 544.19 (55.02) 430.22 (32.56) 355.67 (18.36) 306.94 (16.73) 226.57 (46.43) 8164.42 <0.001 0.864
TMS; M (SD) # 8.52 (8.14) 5.19 (5.72) 3.12 (3.83) 1.92 (3.33) 1.53 (2.65) 212.15 <0.001 0.142
SDMT + 38.67 (11.40)
(n = 135)
43.03 (11.79)
(n = 1232)
48.08 (11.07)
(n = 1204)
51.86 (10.96)
(n = 917)
54.36 (10.83)
(n = 1627)
226.91 <0.001 0.151
VFc + 17.86 (5.39)
(n = 134)
19.44 (5.69)
(n = 1235)
21.00 (5.51)
(n = 1201)
22.08 (5.64)
(n = 914)
22.38 (5.65)
(n = 1625)
66.045 <0.001 0.049
SCNT + 60.49 (15.00)
(n = 136)
66.50 (14.52)
(n = 1230)
71.84 (14.21)
(n = 1199)
74.29 (14.02)
(n = 912)
77.09 (13.96)
(n = 1625)
125.97 <0.001 0.090
SWRT + 77.78 (16.96)
(n = 135)
85.84 (19.05)
(n = 1232)
92.44 (17.14)
(n = 1200)
95.59 (17.67)
(n = 913)
97.76 (17.16)
(n = 1626)
108.47 <0.001 0.078
SIT + 35.88 (11.18)
(n = 128)
38.26 (10.92)
(n = 1161)
42.64 (10.88)
(n = 1133)
44.84 (10.65)
(n = 856)
46.32 (10.68)
(n = 1547)
113.06 <0.001 0.086
Clinical rater (PBA-s)
Depression;
M (SD) #
3.91 (5.90)
(n = 137)
4.84 (6.40)
(n = 1238)
4.44 (5.87)
(n = 1213)
4.46 (5.85)
(n = 917)
3.80 (5.27)
(n = 1627)
6.148 <0.001 0.005
Irritability;
M (SD) #
1.78 (3.65) 2.20 (4.03) 2.18 (3.75) 1.83 (3.25) 1.84 (3.25) 3.18 <0.050 0.002
Psychosis;
M (SD) #
0.04 (0.38) 0.17 (1.51) 0.15 (1.05) 0.11 (0.88) 0.09 (0.78) 1.58 0.177 0.001
Apathy;
M (SD) #
1.00 (2.28) 1.27 (2.74) 1.05 (2.47) 0.94 (2.39) 0.74 (1.96) 9.05 <0.001 0.007
Executive function;
M (SD) #
0.92 (2.46) 1.35 (3.28) 1.37 3.18) 1.27 (3.25) 1.20 (3.00) 1.11 0.350 0.001
Self-report (HADS-IS)
Anxiety; M (SD) # 5.35 (3.90)
(n = 82)
5.54 (3.94)
(n = 804)
5.68 (4.00)
(n = 837)
5.91 (4.22)
(n = 641)
5.47 (3.94)
(n = 1179)
1.47 0.208 0.002
Depression;
M (SD) #
3.61 (3.65) 4.09 (3.66) 3.82 (3.60) 3.72 (3.71) 3.01 (3.12) 13.48 <0.001 0.015
Irritability;
M (SD) #
5.38 (4.11) 5.32 (4.15) 5.18 (4.02) 5.17 (4.10) 4.69 (3.88) 3.74 <0.010 0.004
Outward irritability;
M (SD) #
3.39 (2.69) 3.37 (2.52) 3.31 (2.56) 3.13 (2.43) 2.96 (2.43) 4.17 <0.010 0.005
Inward irritability;
M (SD) #
1.99 (2.02) 1.96 (2.20) 1.86 (2.06) 2.05 (2.35) 1.73 (2.05) 2.80 <0.050 0.003